zimmer biomet make measur progress chang
fve
conduct analyst
govern code ethics/cod conduct
polici secur trade polici
equival invest research
interest visit
primari analyst cover compani
stock
research apr
estim apr
price data apr
rate updat apr
currenc amount express
methodolog valu compani
result
consist temper expect full year
leav valuat unchang
firm made substanti progress earlier inventori
issu regulatori hurdl food drug
administr legaci biomet manufactur facil
remain open matter manag expect remedi
effort wrap end year howev fda
work timelin reinspect might take
place despit oper regulatori
turbul hamper zimmer biomet last
two year remain confid firm wide econom
moat remain intact thank primarili high switch cost
practition secondarili consolid vendor
hospit favor zimmer biomet larg pool
zimmer biomet saw report revenu fall year
year substanti foreign currenc headwind muffl
growth constant currenc though zimmer
biomet continu significantli lag behind
built head steam thank mako robot
still saw stronger growth rival johnson johnson
constant currenc beat declin knee
importantli underli volum growth zimmer biomet
larg knee hip -- support
manag content resolv linger
confid underli demand zimmer biomet
implant remain healthi despit recent inventori
quarterli price eros larg joint
slightli higher market though wholli
unexpect zimmer biomet yet reap
valuat summari forecast
financi summari forecast
historical/forecast data sourc morningstar estim may reflect adjust
zimmer biomet design manufactur market orthoped
reconstruct implant well suppli surgic equip
orthoped surgeri acquisit centerpuls biomet
zimmer hold lead share reconstruct market
unit state europ japan roughli total revenu deriv
sale larg joint anoth come extrem trauma
remain portion primarili relat spine dental product
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
page
reward product mix relat signific adopt
manag
lead
see critic mass rosa robot instal
expect improv price driven shift toward higher-
margin devic consum sold use robot
whole remain optimist rosa
remain earli stage soft launch
confer driven primarili interest rosa robot
receiv total knee replac indic late last
year stark contrast confer
zimmer biomet receiv less lead think
featur rosa fairli distinct
attract practition includ dynam track
allow robot move patient move without
attach patient
firm must priorit manag lead
appropri convert robot sale
hearten see practition interest technolog
think bode well zimmer biomet present strong
competit watch convers lead
next quarter hint well zimmer
biomet abl execut
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
page
financi summari forecast
fiscal year end decemb
earn interest tax
return asset
return equiti
valuat summari forecast
equiti
pre-tax debt
weight averag capit
addit estim scenario avail download http //select morningstar com
equival
data tabl repres base-cas forecast compani report
currenc begin current year fair valu estim may differ
equiti valu per share shown due time valu money adjust case
probability-weight scenario analysi perform
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
page
fiscal year end decemb
good sold
depreci amort report separ
impair charg report separ
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
